Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:58 PM
Ignite Modification Date:
2025-12-24 @ 7:58 PM
NCT ID:
NCT02835404
Eligibility Criteria:
Inclusion Criteria:
* 1\. To be aged from 18 (including 18) to 65 (including 65), female patient;
* 2\. Expected survival ≥6 months
* 3\. Pathologically proven diagnosis of squamous carcinoma or adenocarcinoma of the cervix, according to FIGO(International Federation of Gynecology and Obstetrics) staging, appropriate stage for protocol entry, including IIA2, IIB,IIIA,IIIB;
* 4\. No patients with distant metastases;
* 5\. Measurable target lesions (satisfying the criteria in RECIST 1.1);
* 6\. ECOG PS status of 0-2;
* 7\. No prior treatment;
* 8\. No
* 9\. No surgery
* 10\. Major organ function has to meet the following criteria:
1. Bilirubin \<1.5 times the upper limit of normal (ULN)
2. ALT , AST and APL≤2.5 × ULN
3. NEUT≥2.0 × 10\^9 / L
4. PLT ≥ 100 × 10\^9 / L
5. HB≥60g/L
6. Serum Cr and urea nitrogen ≤ 1.5 × ULN
* 11\. Favorable cardiac functions, no patients with myocardial infarction within half a year, hypertension and coronary disease are well-controlled.
Exclusion Criteria:
* 1\. Serious heart disease, pulmonary disease, hepatic disease, , renal disease and metabolic disease, or with electrolyte disturbance;
* 2\. Allergic to platinum;
* 3\. Rejecte to join the study in other conditions.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT02835404
Study Brief:
Protocol Section:
NCT02835404